Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Declines By 63.7%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a significant decline in short interest in January. As of January 15th, there was short interest totaling 1,641 shares, a decline of 63.7% from the December 31st total of 4,523 shares. Currently, 1.1% of the shares of the company are sold short. Based on an average daily volume of 1,499 shares, the days-to-cover ratio is presently 1.1 days. Based on an average daily volume of 1,499 shares, the days-to-cover ratio is presently 1.1 days. Currently, 1.1% of the shares of the company are sold short.

iShares Neuroscience and Healthcare ETF Stock Performance

Shares of IBRN opened at $33.37 on Wednesday. The stock has a market capitalization of $5.01 million, a price-to-earnings ratio of 15.61 and a beta of 0.93. iShares Neuroscience and Healthcare ETF has a 52-week low of $17.86 and a 52-week high of $37.00. The stock’s 50-day simple moving average is $31.96 and its 200 day simple moving average is $28.19.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.